本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Standard BioTools Inc.

1.08
+0.02001.89%
成交量:117.10万
成交额:125.50万
市值:4.10亿
市盈率:-3.04
高:1.09
开:1.07
低:1.04
收:1.06
数据加载中...
2024/01/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/26

重要事件披露

Form 8-K - Current report
2023/12/26

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/04

重要事件披露

Form 8-K - Current report
2023/12/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/12/01

SEC问询函

Form CORRESP - Correspondence
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/22

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/22

重要事件披露

Form 8-K - Current report